Trade secret protection in Israel does not depend on registration, a government certificate or an application to the Israel Patent Office. It depends on the nature of the information and on how its lawful holder protects it. For a foreign company considering action against a former employee, business partner or competitor in Israel, the first question is whether the particular information qualifies as a trade secret under Israeli law.
Section 5 of the Commercial Torts Law, 5759-1999, sets out four cumulative requirements. The subject matter must be business information; it must not be in the public domain or readily discoverable by lawful means; its secrecy must provide a business advantage over competitors; and its owner must take reasonable steps to preserve that secrecy. Establishing unauthorized use is not enough if the information itself fails this statutory test.
What types of information can qualify as trade secrets?
The statutory definition of business information is broad. Trade secrets may include formulas, manufacturing processes, technical drawings, source code, algorithms and engineering know-how. They may also consist of non-technical information such as business plans, pricing models, contractual terms, costs and margins, marketing strategies, supplier data and detailed customer information.
In Gmida v. Fisher, Tel Aviv District Court, Civil Case 2117/07 (5 December 2012), the disputed material included business plans, prices, customer-facing work methods and other commercial information. The court emphasized that the statutory definition is not confined to technological secrets.
Unlike patent law, trade secret law does not require an inventive or novel technical contribution. An otherwise familiar set of data may merit protection when its particular combination, arrangement or contents are not generally known, provide a competitive advantage and remain confidential. Conversely, a broad business idea or an abstract description of a method does not become a trade secret merely because its proponent considers it valuable.
Secrecy is essential, but it need not be absolute
Information that has become publicly available, or that competitors can lawfully obtain without difficulty, will not qualify. The question is not whether anyone outside the business has ever seen it. It is whether the information remains outside the relevant public domain and is not readily discoverable through legitimate means.
Employees, consultants, suppliers, investors and commercial partners may need access to protected information. Such disclosure does not necessarily destroy secrecy if access is controlled and the circumstances support confidentiality obligations. Israeli case law, including Elite v. Saranga, addresses the relative nature of protection for confidential information.
In Rahmani D.A.M. Earthworks Ltd. v. State of Israel, case 39187-04-10 (19 June 2014), a trade secret claim failed in relation to information whose essential elements were already known to relevant parties in the defense establishment. Commercial usefulness by itself could not substitute for secrecy.
At the same time, a non-public compilation may have commercial value even when some individual facts are publicly accessible. In Delek Motors Ltd. v. State of Israel (Customs and VAT), Israeli Supreme Court, Leave to Appeal 8362/17 (4 January 2018), the Court recognized the sensitivity of customer information that included discounts, contractual terms and related commercial data, even where the identities of some customers were not themselves secret.
The information’s secrecy must confer a competitive advantage
The law requires more than information that happens not to be public. Its confidentiality must give the holder an advantage over competitors. That advantage may take the form of avoided research and development costs, more accurate pricing, insight into customers’ requirements, a stronger negotiating position or the ability to act on commercial intelligence unavailable to competitors.
The relevant value arises from secrecy. If a competitor’s access to the information would make no meaningful difference to its commercial position, this requirement may be difficult to establish. The information need not be the company’s most valuable asset or independently generate revenue, but the competitive advantage must be identifiable.
Identify the trade secret precisely before alleging misappropriation
A recurring weakness in Israeli trade secret claims is an overly general description of the protected material. References to a company’s “know-how,” “method,” “connections,” “technology” or “business information,” without further particulars, do not allow a court to assess what is secret, what advantage it provides or what was allegedly taken or used.
The claimant must be able to identify the information with sufficient specificity to distinguish it from public information and an individual’s general professional experience. In S.P.G. Communication Center Ltd. v. Elta Systems Ltd., Central District Court, Civil Case 30839-02-11 (18 September 2016), the trade secret claim was dismissed where the claimant failed to establish the alleged confidential information, the steps taken to protect it and its transmission to a competitor.
For foreign counsel preparing an Israeli claim, this makes the description of the information and the supporting record particularly important. Confidential documents, access restrictions, relevant agreements and evidence of the circumstances of the alleged disclosure should support the same clearly identified subject matter.
What are reasonable measures to protect secrecy?
An owner’s intention to keep information confidential is not sufficient. Section 5 requires reasonable steps actually taken to preserve secrecy. Absolute security is not required; the measures are assessed in light of the nature and value of the information, the number of people who need access and the foreseeable risks of disclosure.
Depending on the business, appropriate measures may include role-based access permissions, separating sensitive files and databases, password and system security, confidentiality markings, limits on copying and onward transfer, internal procedures, and disclosure only to people who need the information for their work. Confidentiality agreements can define the permitted purpose and scope of disclosure to investors, prospective business partners, service providers and other third parties.
No single safeguard is mandatory in every situation. Organizational, technological and contractual measures may operate together. Conversely, information freely accessible across an organization, circulated to people who have no need for it or disclosed externally without meaningful restrictions may be difficult to characterize as a protected secret.
Customer lists are not automatically trade secrets
A list of names assembled from public sources is not protected merely because it is kept in a company’s database. The potentially protected value may lie in associated non-public information: purchasing histories, negotiated prices, discounts, customer preferences, renewal dates, credit terms, profitability and other data that allow a competitor to approach customers with an advantage unavailable to the market generally.
The assessment therefore turns on the contents of the list, how readily that information can be obtained, the competitive value of secrecy and the safeguards used. This distinction is especially important in disputes involving departing employees and competing businesses. Israeli decisions, including Batan v. Integra, illustrate the need to examine the specific information rather than assume that every customer list is confidential.
Independent development and reverse engineering
Trade secret protection does not give its holder an exclusive right against anyone who independently arrives at the same information. A competitor who develops an equivalent solution without using the claimant’s confidential information does not misappropriate the claimant’s trade secret merely because the results are similar.
Reverse engineering is also not wrongful in itself. Section 6(c) of the Commercial Torts Law provides that discovering a trade secret by reverse engineering does not, by itself, constitute an improper means of acquisition under Section 6(b)(1). The effort required to discover information may matter when assessing whether it is readily ascertainable, but a difficult reverse-engineering exercise does not become misappropriation merely because it required substantial effort.
The distinction is between legitimate independent discovery and obtaining an advantage through another party’s protected information. Access secured through unauthorized entry into computer systems, breach of confidence, breach of a contractual duty or other wrongful conduct calls for a different legal analysis under Section 6.
Trade secret protection compared with patents
A patent, if valid and enforceable, may prevent third parties from exploiting the claimed invention even if they developed it independently. In return, the applicant must satisfy the conditions for patentability, follow the registration process and disclose the invention in the application. A trade secret requires no registration and has no predetermined expiry date, but it does not prevent lawful independent development or reverse engineering.
Whether to seek patent protection or preserve technical information as a trade secret is therefore a commercial as well as a legal decision. The feasibility of maintaining secrecy, the ease with which competitors could analyze the product and the consequences of disclosing the technology are central considerations.
How long does trade secret protection last in Israel?
There is no fixed statutory term. Protection can continue for as long as the information meets the requirements of Section 5, potentially for many years. It may also end rapidly if the information is published, becomes readily discoverable or no longer provides an advantage through secrecy.
A business relying on trade secret protection should maintain a current understanding of what it treats as confidential, who has access, the basis on which information is disclosed to others and whether the safeguards remain appropriate. If information is taken, transmitted or used without authorization, a separate inquiry under Section 6 is required to determine whether the conduct constitutes misappropriation. Such disputes fall within the wider field of trade secret litigation in Israel.
